{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:48:57Z","timestamp":1794278937578,"version":"4.9.0"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T00:00:00Z","timestamp":1683244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21gm1010002, JP22bm0804005, and JP22ek0109488"],"award-info":[{"award-number":["JP21gm1010002, JP22bm0804005, and JP22ek0109488"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20H03561"],"award-info":[{"award-number":["JP20H03561"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K17343"],"award-info":[{"award-number":["JP22K17343"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K15394"],"award-info":[{"award-number":["JP22K15394"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["20FC1036"],"award-info":[{"award-number":["20FC1036"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009438","name":"National Center of Neurology and Psychiatry","doi-asserted-by":"publisher","award":["2-5"],"award-info":[{"award-number":["2-5"]}],"id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005694","name":"Hori Sciences and Arts Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005694","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Parkinson\u2019s disease (PD) is pathologically characterized by the abnormal accumulation of \u03b1-synuclein fibrils (Lewy bodies) in the substantia nigra and other brain regions, although the role of Lewy bodies remains elusive. Constipation usually precedes the motor symptoms in PD, which is in accordance with the notion that \u03b1-synuclein fibrils start from the intestinal neural plexus and ascend to the brain in at least half of PD patients. The gut microbiota is likely to be involved in intestinal and brain pathologies. Analyses of the gut microbiota in PD, rapid-eye-movement sleep behavior disorder, and dementia with Lewy bodies suggest three pathological pathways. First,\n                    <jats:italic>Akkermansia<\/jats:italic>\n                    , which is increased in PD, degrades the intestinal mucus layer and increases intestinal permeability, which triggers inflammation and oxidative stress in the intestinal neural plexus. Second, decreased short-chain fatty acids (SCFAs)-producing bacteria in PD reduce the number of regulatory T cells. Third, SCFAs also aggravate microglial activation with an unelucidated pathway. In addition, in dementia with Lewy bodies (DLB), which is another form of \u03b1-synucleinopathies, increased genera,\n                    <jats:italic>Ruminococcus torques<\/jats:italic>\n                    and\n                    <jats:italic>Collinsella<\/jats:italic>\n                    , may mitigate neuroinflammation in the substantia nigra by increasing secondary bile acids. Interventions for the gut microbiota and their metabolites may potentially delay or mitigate the development and progression of PD and other Lewy body diseases.\n                  <\/jats:p>","DOI":"10.1038\/s41531-023-00511-2","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T02:02:45Z","timestamp":1683252165000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Gastrointestinal disorders in Parkinson\u2019s disease and other Lewy body diseases"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0092-7837","authenticated-orcid":false,"given":"Masaaki","family":"Hirayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nishiwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonari","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1529-2750","authenticated-orcid":false,"given":"Kinji","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,5]]},"reference":[{"key":"511_CR1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.parkreldis.2017.02.024","volume":"38","author":"T Maeda","year":"2017","unstructured":"Maeda, T. et al. Clinical manifestations of nonmotor symptoms in 1021 Japanese Parkinson\u2019s disease patients from 35 medical centers. Parkinsonism Relat. Disord. 38, 54\u201360 (2017).","journal-title":"Parkinsonism Relat. Disord."},{"key":"511_CR2","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1212\/WNL.57.3.456","volume":"57","author":"RD Abbott","year":"2001","unstructured":"Abbott, R. D. et al. Frequency of bowel movements and the future risk of Parkinson\u2019s disease. Neurology 57, 456\u2013462 (2001).","journal-title":"Neurology"},{"key":"511_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/2045-9912-2-15","volume":"2","author":"M Ito","year":"2012","unstructured":"Ito, M. et al. Drinking hydrogen water and intermittent hydrogen gas exposure, but not lactulose or continuous hydrogen gas exposure, prevent 6-hydorxydopamine-induced Parkinson\u2019s disease in rats. Med. Gas. Res. 2, 15 (2012).","journal-title":"Med. Gas. Res."},{"key":"511_CR4","doi-asserted-by":"publisher","first-page":"III\/1","DOI":"10.1007\/s00415-002-1301-4","volume":"249","author":"H Braak","year":"2002","unstructured":"Braak, H. et al. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson\u2019s disease (preclinical and clinical stages). J. Neurol. 249, III\/1\u2013III\/5 (2002).","journal-title":"J. Neurol."},{"key":"511_CR5","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1093\/brain\/awm056","volume":"130","author":"BF Boeve","year":"2007","unstructured":"Boeve, B. F. et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 130, 2770\u20132788 (2007).","journal-title":"Brain"},{"key":"511_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","volume":"33","author":"CH Hawkes","year":"2007","unstructured":"Hawkes, C. H., Del Tredici, K. & Braak, H. Parkinson\u2019s disease: a dual-hit hypothesis. Neuropathol. Appl. Neurobiol. 33, 599\u2013614 (2007).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"511_CR7","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.nbd.2011.10.014","volume":"46","author":"MG Cersosimo","year":"2012","unstructured":"Cersosimo, M. G. & Benarroch, E. E. Pathological correlates of gastrointestinal dysfunction in Parkinson\u2019s disease. Neurobiol. Dis. 46, 559\u2013564 (2012).","journal-title":"Neurobiol. Dis."},{"key":"511_CR8","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ana.24448","volume":"78","author":"E Svensson","year":"2015","unstructured":"Svensson, E. et al. Vagotomy and subsequent risk of Parkinson\u2019s disease. Ann. Neurol. 78, 522\u2013529 (2015).","journal-title":"Ann. Neurol."},{"key":"511_CR9","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1212\/WNL.0000000000003961","volume":"88","author":"B Liu","year":"2017","unstructured":"Liu, B. et al. Vagotomy and Parkinson disease: a Swedish register-based matched-cohort study. Neurology 88, 1996\u20132002 (2017).","journal-title":"Neurology"},{"key":"511_CR10","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1093\/brain\/awaa238","volume":"143","author":"J Horsager","year":"2020","unstructured":"Horsager, J. et al. Brain-first versus body-first Parkinson\u2019s disease: a multimodal imaging case-control study. Brain 143, 3077\u20133088 (2020).","journal-title":"Brain"},{"key":"511_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.dld.2018.09.017","volume":"51","author":"F Zhu","year":"2019","unstructured":"Zhu, F. et al. The risk of Parkinson\u2019s disease in inflammatory bowel disease: A systematic review and meta-analysis. Dig. Liver Dis. 51, 38\u201342 (2019).","journal-title":"Dig. Liver Dis."},{"key":"511_CR12","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1001\/jamaneurol.2018.0605","volume":"75","author":"I Peter","year":"2018","unstructured":"Peter, I. et al. Anti-tumor necrosis factor therapy and incidence of Parkinson disease among patients with inflammatory bowel disease. JAMA Neurol. 75, 939\u2013946 (2018).","journal-title":"JAMA Neurol."},{"key":"511_CR13","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3390\/jcm8081191","volume":"8","author":"S Park","year":"2019","unstructured":"Park, S. et al. Patients with inflammatory bowel disease are at an increased risk of Parkinson\u2019s disease: a South Korean nationwide population-based study. J. Clin. Med. 8, 1191 (2019).","journal-title":"J. Clin. Med."},{"key":"511_CR14","doi-asserted-by":"publisher","first-page":"290","DOI":"10.15403\/jgld-4313","volume":"31","author":"N Gibo","year":"2022","unstructured":"Gibo, N. et al. Examination of abnormal alpha-synuclein aggregates in the enteric neural plexus in patients with ulcerative colitis. J. Gastrointestin. Liver Dis. 31, 290\u2013300 (2022).","journal-title":"J. Gastrointestin. Liver Dis."},{"key":"511_CR15","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/ng.717","volume":"42","author":"A Franke","year":"2010","unstructured":"Franke, A. et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn\u2019s disease susceptibility loci. Nat. Genet. 42, 1118\u20131125 (2010).","journal-title":"Nat. Genet."},{"key":"511_CR16","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nrn2935","volume":"11","author":"MR Cookson","year":"2010","unstructured":"Cookson, M. R. The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson\u2019s disease. Nat. Rev. Neurosci. 11, 791\u2013797 (2010).","journal-title":"Nat. Rev. Neurosci."},{"key":"511_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41531-021-00170-1","volume":"7","author":"MK Herrick","year":"2021","unstructured":"Herrick, M. K. & Tansey, M. G. Is LRRK2 the missing link between inflammatory bowel disease and Parkinson\u2019s disease? NPJ Parkinsons Dis. 7, 26 (2021).","journal-title":"NPJ Parkinsons Dis."},{"key":"511_CR18","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey, M. G. et al. Inflammation and immune dysfunction in Parkinson disease. Nat. Rev. Immunol. 22, 657\u2013673 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"511_CR19","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim, S. et al. Transneuronal propagation of pathologic alpha-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron 103, 627\u2013641 (2019). e627.","journal-title":"Neuron"},{"key":"511_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.neulet.2017.10.008","volume":"662","author":"S Li","year":"2018","unstructured":"Li, S. et al. Intestinal microbiota impact sepsis associated encephalopathy via the vagus nerve. Neurosci. Lett. 662, 98\u2013104 (2018).","journal-title":"Neurosci. Lett."},{"key":"511_CR21","doi-asserted-by":"publisher","first-page":"eaar5280","DOI":"10.1126\/scitranslmed.aar5280","volume":"10","author":"BA Killinger","year":"2018","unstructured":"Killinger, B. A. et al. The vermiform appendix impacts the risk of developing Parkinson\u2019s disease. Sci. Transl. Med. 10, eaar5280 (2018).","journal-title":"Sci. Transl. Med."},{"key":"511_CR22","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1002\/mds.109","volume":"33","author":"N Palacios","year":"2018","unstructured":"Palacios, N., Hughes, K. C., Cereda, E., Schwarzschild, M. A. & Ascherio, A. Appendectomy and risk of Parkinson\u2019s disease in two large prospective cohorts of men and women. Mov. Disord. 33, 1492\u20131496 (2018).","journal-title":"Mov. Disord."},{"key":"511_CR23","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/mds.25779","volume":"29","author":"MT Gray","year":"2014","unstructured":"Gray, M. T., Munoz, D. G., Gray, D. A., Schlossmacher, M. G. & Woulfe, J. M. Alpha-synuclein in the appendiceal mucosa of neurologically intact subjects. Mov. Disord. 29, 991\u2013998 (2014).","journal-title":"Mov. Disord."},{"key":"511_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/978-1-4939-0897-4_5","volume":"817","author":"P Forsythe","year":"2014","unstructured":"Forsythe, P., Bienenstock, J. & Kunze, W. A. Vagal pathways for microbiome-brain-gut axis communication. Adv. Exp. Med. Biol. 817, 115\u2013133 (2014).","journal-title":"Adv. Exp. Med. Biol."},{"key":"511_CR25","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1159\/000477990","volume":"9","author":"E Stolzenberg","year":"2017","unstructured":"Stolzenberg, E. et al. A role for neuronal alpha-synuclein in gastrointestinal immunity. J. Innate Immun. 9, 456\u2013463 (2017).","journal-title":"J. Innate Immun."},{"key":"511_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/srep34477","volume":"6","author":"SG Chen","year":"2016","unstructured":"Chen, S. G. et al. Exposure to the functional bacterial amyloid protein curli enhances alpha-synuclein aggregation in aged Fischer 344 rats and Caenorhabditis elegans. Sci. Rep. 6, 34477 (2016).","journal-title":"Sci. Rep."},{"key":"511_CR27","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/mds.25736","volume":"29","author":"LP Kelly","year":"2014","unstructured":"Kelly, L. P. et al. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson\u2019s disease. Mov. Disord. 29, 999\u20131009 (2014).","journal-title":"Mov. Disord."},{"key":"511_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/srep30891","volume":"6","author":"C Kim","year":"2016","unstructured":"Kim, C. et al. Exposure to bacterial endotoxin generates a distinct strain of alpha-synuclein fibril. Sci. Rep. 6, 30891 (2016).","journal-title":"Sci. Rep."},{"key":"511_CR29","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1289\/ehp.1306967","volume":"121","author":"H Chen","year":"2013","unstructured":"Chen, H. et al. Research on the premotor symptoms of Parkinson\u2019s disease: clinical and etiological implications. Environ. Health Perspect. 121, 1245\u20131252 (2013).","journal-title":"Environ. Health Perspect."},{"key":"511_CR30","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1289\/ehp.1002839","volume":"119","author":"CM Tanner","year":"2011","unstructured":"Tanner, C. M. et al. Rotenone, paraquat, and Parkinson\u2019s disease. Environ. Health Perspect. 119, 866\u2013872 (2011).","journal-title":"Environ. Health Perspect."},{"key":"511_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1006\/exnr.2002.8072","volume":"179","author":"TB Sherer","year":"2003","unstructured":"Sherer, T. B., Kim, J. H., Betarbet, R. & Greenamyre, J. T. Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp. Neurol. 179, 9\u201316 (2003).","journal-title":"Exp. Neurol."},{"key":"511_CR32","doi-asserted-by":"publisher","first-page":"e8762","DOI":"10.1371\/journal.pone.0008762","volume":"5","author":"F Pan-Montojo","year":"2010","unstructured":"Pan-Montojo, F. et al. Progression of Parkinson\u2019s disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS ONE 5, e8762 (2010).","journal-title":"PLoS ONE"},{"key":"511_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/srep00898","volume":"2","author":"F Pan-Montojo","year":"2012","unstructured":"Pan-Montojo, F. et al. Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice. Sci. Rep. 2, 898 (2012).","journal-title":"Sci. Rep."},{"key":"511_CR34","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/0016-5085(84)90079-9","volume":"87","author":"SJ Qualman","year":"1984","unstructured":"Qualman, S. J., Haupt, H. M., Yang, P. & Hamilton, S. R. Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson\u2019s disease. Gastroenterology 87, 848\u2013856 (1984).","journal-title":"Gastroenterology"},{"key":"511_CR35","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/BF00294234","volume":"79","author":"K Wakabayashi","year":"1990","unstructured":"Wakabayashi, K., Takahashi, H., Ohama, E. & Ikuta, F. Parkinson\u2019s disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathol. 79, 581\u2013583 (1990).","journal-title":"Acta Neuropathol."},{"key":"511_CR36","doi-asserted-by":"publisher","first-page":"eaat5236","DOI":"10.1126\/science.aat5236","volume":"361","author":"MM Kaelberer","year":"2018","unstructured":"Kaelberer, M. M. et al. A gut-brain neural circuit for nutrient sensory transduction. Science 361, eaat5236 (2018).","journal-title":"Science"},{"key":"511_CR37","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.cell.2018.08.049","volume":"175","author":"W Han","year":"2018","unstructured":"Han, W. et al. A neural circuit for gut-induced reward. Cell 175, 665\u2013678 (2018). e623.","journal-title":"Cell"},{"key":"511_CR38","doi-asserted-by":"publisher","first-page":"e92295","DOI":"10.1172\/jci.insight.92295","volume":"2","author":"R Chandra","year":"2017","unstructured":"Chandra, R., Hiniker, A., Kuo, Y. M., Nussbaum, R. L. & Liddle, R. A. alpha-Synuclein in gut endocrine cells and its implications for Parkinson\u2019s disease. JCI Insight 2, e92295 (2017).","journal-title":"JCI Insight"},{"key":"511_CR39","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/mds.25020","volume":"27","author":"KM Shannon","year":"2012","unstructured":"Shannon, K. M., Keshavarzian, A., Dodiya, H. B., Jakate, S. & Kordower, J. H. Is alpha-synuclein in the colon a biomarker for premotor Parkinson\u2019s disease? Evidence from 3 cases. Mov. Disord. 27, 716\u2013719 (2012).","journal-title":"Mov. Disord."},{"key":"511_CR40","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00401-013-1214-6","volume":"127","author":"D Hilton","year":"2014","unstructured":"Hilton, D. et al. Accumulation of alpha-synuclein in the bowel of patients in the pre-clinical phase of Parkinson\u2019s disease. Acta Neuropathol. 127, 235\u2013241 (2014).","journal-title":"Acta Neuropathol."},{"key":"511_CR41","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/BF00687767","volume":"76","author":"K Wakabayashi","year":"1988","unstructured":"Wakabayashi, K., Takahashi, H., Takeda, S., Ohama, E. & Ikuta, F. Parkinson\u2019s disease: the presence of Lewy bodies in Auerbach\u2019s and Meissner\u2019s plexuses. Acta Neuropathol. 76, 217\u2013221 (1988).","journal-title":"Acta Neuropathol."},{"key":"511_CR42","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","volume":"119","author":"TG Beach","year":"2010","unstructured":"Beach, T. G. et al. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol. 119, 689\u2013702 (2010).","journal-title":"Acta Neuropathol."},{"key":"511_CR43","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/brain\/awu369","volume":"138","author":"T Gjerloff","year":"2015","unstructured":"Gjerloff, T. et al. Imaging acetylcholinesterase density in peripheral organs in Parkinson\u2019s disease with 11C-donepezil PET. Brain 138, 653\u2013663 (2015).","journal-title":"Brain"},{"key":"511_CR44","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1212\/WNL.0000000000003633","volume":"88","author":"TD Fedorova","year":"2017","unstructured":"Fedorova, T. D. et al. Decreased intestinal acetylcholinesterase in early Parkinson disease: an (11)C-donepezil PET study. Neurology 88, 775\u2013781 (2017).","journal-title":"Neurology"},{"key":"511_CR45","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.neulet.2009.12.027","volume":"469","author":"Y Miki","year":"2010","unstructured":"Miki, Y. et al. Clinical availability of skin biopsy in the diagnosis of Parkinson\u2019s disease. Neurosci. Lett. 469, 357\u2013359 (2010).","journal-title":"Neurosci. Lett."},{"key":"511_CR46","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S1474-4422(19)30400-4","volume":"19","author":"F Hopfner","year":"2020","unstructured":"Hopfner, F. et al. beta-adrenoreceptors and the risk of Parkinson\u2019s disease. Lancet Neurol. 19, 247\u2013254 (2020).","journal-title":"Lancet Neurol."},{"key":"511_CR47","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/ana.10277","volume":"52","author":"MA Hernan","year":"2002","unstructured":"Hernan, M. A., Takkouche, B., Caamano-Isorna, F. & Gestal-Otero, J. J. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson\u2019s disease. Ann. Neurol. 52, 276\u2013284 (2002).","journal-title":"Ann. Neurol."},{"key":"511_CR48","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1212\/WNL.58.4.581","volume":"58","author":"CM Tanner","year":"2002","unstructured":"Tanner, C. M. et al. Smoking and Parkinson\u2019s disease in twins. Neurology 58, 581\u2013588 (2002).","journal-title":"Neurology"},{"key":"511_CR49","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/mds.25028","volume":"27","author":"M Quik","year":"2012","unstructured":"Quik, M., Perez, X. A. & Bordia, T. Nicotine as a potential neuroprotective agent for Parkinson\u2019s disease. Mov. Disord. 27, 947\u2013957 (2012).","journal-title":"Mov. Disord."},{"key":"511_CR50","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3109\/00365528909089259","volume":"24","author":"H Prytz","year":"1989","unstructured":"Prytz, H., Benoni, C. & Tagesson, C. Does smoking tighten the gut? Scand. J. Gastroenterol. 24, 1084\u20131088 (1989).","journal-title":"Scand. J. Gastroenterol."},{"key":"511_CR51","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.3748\/wjg.v18.i18.2180","volume":"18","author":"H Wang","year":"2012","unstructured":"Wang, H. et al. Side-stream smoking reduces intestinal inflammation and increases expression of tight junction proteins. World J. Gastroenterol. 18, 2180\u20132187 (2012).","journal-title":"World J. Gastroenterol."},{"key":"511_CR52","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1002\/ibd.21864","volume":"18","author":"JL Benjamin","year":"2012","unstructured":"Benjamin, J. L. et al. Smokers with active Crohn\u2019s disease have a clinically relevant dysbiosis of the gastrointestinal microbiota. Inflamm. Bowel Dis. 18, 1092\u20131100 (2012).","journal-title":"Inflamm. Bowel Dis."},{"key":"511_CR53","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1097\/MIB.0000000000000129","volume":"20","author":"L Biedermann","year":"2014","unstructured":"Biedermann, L. et al. Smoking cessation alters intestinal microbiota: insights from quantitative investigations on human fecal samples using FISH. Inflamm. Bowel Dis. 20, 1496\u20131501 (2014).","journal-title":"Inflamm. Bowel Dis."},{"key":"511_CR54","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1136\/gutjnl-2021-325021","volume":"71","author":"X Bai","year":"2022","unstructured":"Bai, X. et al. Cigarette smoke promotes colorectal cancer through modulation of gut microbiota and related metabolites. Gut 71, 2439\u20132450 (2022).","journal-title":"Gut"},{"key":"511_CR55","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1007\/s10654-011-9581-6","volume":"26","author":"K Wirdefeldt","year":"2011","unstructured":"Wirdefeldt, K., Adami, H. O., Cole, P., Trichopoulos, D. & Mandel, J. Epidemiology and etiology of Parkinson\u2019s disease: a review of the evidence. Eur. J. Epidemiol. 26, S1\u2013S58 (2011).","journal-title":"Eur. J. Epidemiol."},{"key":"511_CR56","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/sj.ejcn.1602365","volume":"60","author":"K Murakami","year":"2006","unstructured":"Murakami, K., Okubo, H. & Sasaki, S. Dietary intake in relation to self-reported constipation among Japanese women aged 18-20 years. Eur. J. Clin. Nutr. 60, 650\u2013657 (2006).","journal-title":"Eur. J. Clin. Nutr."},{"key":"511_CR57","doi-asserted-by":"publisher","first-page":"S205","DOI":"10.3233\/JAD-2010-091459","volume":"20","author":"RD Prediger","year":"2010","unstructured":"Prediger, R. D. Effects of caffeine in Parkinson\u2019s disease: from neuroprotection to the management of motor and non-motor symptoms. J. Alzheimers Dis. 20, S205\u2013S220 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"511_CR58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1348-0421.2011.00398.x","volume":"56","author":"EV Khokhlova","year":"2012","unstructured":"Khokhlova, E. V. et al. Anti-inflammatory properties of intestinal Bifidobacterium strains isolated from healthy infants. Microbiol. Immunol. 56, 27\u201339 (2012).","journal-title":"Microbiol. Immunol."},{"key":"511_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-018-1034-3","volume":"18","author":"J Gan","year":"2018","unstructured":"Gan, J. et al. A survey of subjective constipation in Parkinson\u2019s disease patients in shanghai and literature review. BMC Neurol. 18, 29 (2018).","journal-title":"BMC Neurol."},{"key":"511_CR60","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.dld.2005.06.008","volume":"37","author":"IL Khalif","year":"2005","unstructured":"Khalif, I. L., Quigley, E. M., Konovitch, E. A. & Maximova, I. D. Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation. Dig. Liver Dis. 37, 838\u2013849 (2005).","journal-title":"Dig. Liver Dis."},{"key":"511_CR61","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1136\/gutjnl-2020-323877","volume":"70","author":"F Asnicar","year":"2021","unstructured":"Asnicar, F. et al. Blue poo: impact of gut transit time on the gut microbiome using a novel marker. Gut 70, 1665\u20131674 (2021).","journal-title":"Gut"},{"key":"511_CR62","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/mds.28119","volume":"35","author":"H Nishiwaki","year":"2020","unstructured":"Nishiwaki, H. et al. Meta-analysis of gut dysbiosis in Parkinson\u2019s disease. Mov. Disord. 35, 1626\u20131635 (2020).","journal-title":"Mov. Disord."},{"key":"511_CR63","doi-asserted-by":"publisher","first-page":"e0142164","DOI":"10.1371\/journal.pone.0142164","volume":"10","author":"S Hasegawa","year":"2015","unstructured":"Hasegawa, S. et al. Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson\u2019s disease. PLoS ONE 10, e0142164 (2015).","journal-title":"PLoS ONE"},{"key":"511_CR64","doi-asserted-by":"publisher","first-page":"e28032","DOI":"10.1371\/journal.pone.0028032","volume":"6","author":"CB Forsyth","year":"2011","unstructured":"Forsyth, C. B. et al. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson\u2019s disease. PLoS ONE 6, e28032 (2011).","journal-title":"PLoS ONE"},{"key":"511_CR65","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","volume":"32","author":"MM Unger","year":"2016","unstructured":"Unger, M. M. et al. Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls. Parkinsonism Relat. Disord. 32, 66\u201372 (2016).","journal-title":"Parkinsonism Relat. Disord."},{"key":"511_CR66","doi-asserted-by":"publisher","first-page":"e0187307","DOI":"10.1371\/journal.pone.0187307","volume":"12","author":"T Minato","year":"2017","unstructured":"Minato, T. et al. Progression of Parkinson\u2019s disease is associated with gut dysbiosis: two-year follow-up study. PLoS ONE 12, e0187307 (2017).","journal-title":"PLoS ONE"},{"key":"511_CR67","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.brainres.2017.04.019","volume":"1667","author":"F Hopfner","year":"2017","unstructured":"Hopfner, F. et al. Gut microbiota in Parkinson disease in a northern German cohort. Brain Res. 1667, 41\u201345 (2017).","journal-title":"Brain Res."},{"key":"511_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-017-0428-y","volume":"9","author":"JR Bedarf","year":"2017","unstructured":"Bedarf, J. R. et al. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naive Parkinson\u2019s disease patients. Genome Med. 9, 39 (2017).","journal-title":"Genome Med."},{"key":"511_CR69","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.parkreldis.2018.05.007","volume":"53","author":"A Lin","year":"2018","unstructured":"Lin, A. et al. Gut microbiota in patients with Parkinson\u2019s disease in southern China. Parkinsonism Relat. Disord. 53, 82\u201388 (2018).","journal-title":"Parkinsonism Relat. Disord."},{"key":"511_CR70","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ebiom.2019.05.064","volume":"44","author":"VTE Aho","year":"2019","unstructured":"Aho, V. T. E. et al. Gut microbiota in Parkinson\u2019s disease: temporal stability and relations to disease progression. EBioMedicine 44, 691\u2013707 (2019).","journal-title":"EBioMedicine"},{"key":"511_CR71","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41531-021-00156-z","volume":"7","author":"S Romano","year":"2021","unstructured":"Romano, S. et al. Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation. npj Parkinsons Dis. 7, 27 (2021).","journal-title":"npj Parkinsons Dis."},{"key":"511_CR72","doi-asserted-by":"publisher","first-page":"e848","DOI":"10.1212\/WNL.0000000000013225","volume":"98","author":"SJ Chen","year":"2022","unstructured":"Chen, S. J. et al. Association of fecal and plasma levels of short-chain fatty acids with gut microbiota and clinical severity in patients with Parkinson disease. Neurology 98, e848\u2013e858 (2022).","journal-title":"Neurology"},{"key":"511_CR73","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1093\/brain\/awaa201","volume":"143","author":"Y Qian","year":"2020","unstructured":"Qian, Y. et al. Gut metagenomics-derived genes as potential biomarkers of Parkinson\u2019s disease. Brain 143, 2474\u20132489 (2020).","journal-title":"Brain"},{"key":"511_CR74","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41531-022-00328-5","volume":"8","author":"H Nishiwaki","year":"2022","unstructured":"Nishiwaki, H. et al. Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson\u2019s disease. npj Parkinsons Dis. 8, 65 (2022).","journal-title":"npj Parkinsons Dis."},{"key":"511_CR75","doi-asserted-by":"publisher","first-page":"e00797","DOI":"10.1128\/mSystems.00797-20","volume":"5","author":"H Nishiwaki","year":"2020","unstructured":"Nishiwaki, H. et al. Short-chain fatty acid-producing gut microbiota is decreased in Parkinson\u2019s disease but not in rapid-eye-movement sleep behavior disorder. mSystems 5, e00797\u201320 (2020).","journal-title":"mSystems"},{"key":"511_CR76","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/mds.27105","volume":"33","author":"A Heintz-Buschart","year":"2018","unstructured":"Heintz-Buschart, A. et al. The nasal and gut microbiome in Parkinson\u2019s disease and idiopathic rapid eye movement sleep behavior disorder. Mov. Disord. 33, 88\u201398 (2018).","journal-title":"Mov. Disord."},{"key":"511_CR77","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith, I. G. et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89, 88\u2013100 (2017).","journal-title":"Neurology"},{"key":"511_CR78","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-019-0306-8","volume":"14","author":"TF Outeiro","year":"2019","unstructured":"Outeiro, T. F. et al. Dementia with Lewy bodies: an update and outlook. Mol. Neurodegener. 14, 5 (2019).","journal-title":"Mol. Neurodegener."},{"key":"511_CR79","first-page":"435","volume":"22","author":"SN Gomperts","year":"2016","unstructured":"Gomperts, S. N. Lewy body dementias: dementia with Lewy bodies and Parkinson disease dementia. Continuum 22, 435\u2013463 (2016).","journal-title":"Continuum"},{"key":"511_CR80","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41531-022-00428-2","volume":"8","author":"H Nishiwaki","year":"2022","unstructured":"Nishiwaki, H. et al. Gut microbiota in dementia with Lewy bodies. npj Parkinsons Dis. 8, 169 (2022).","journal-title":"npj Parkinsons Dis."},{"key":"511_CR81","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3233\/JAD-180176","volume":"63","author":"ZQ Zhuang","year":"2018","unstructured":"Zhuang, Z. Q. et al. Gut microbiota is altered in patients with Alzheimer\u2019s disease. J. Alzheimers Dis. 63, 1337\u20131346 (2018).","journal-title":"J. Alzheimers Dis."},{"key":"511_CR82","doi-asserted-by":"publisher","first-page":"e00632","DOI":"10.1128\/mBio.00632-19","volume":"10","author":"JP Haran","year":"2019","unstructured":"Haran, J. P. et al. Alzheimer\u2019s disease microbiome is associated with dysregulation of the anti-inflammatory P-glycoprotein pathway. mBio 10, e00632\u201319 (2019).","journal-title":"mBio"},{"key":"511_CR83","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3920\/BM2018.0170","volume":"10","author":"Y Kobayashi","year":"2019","unstructured":"Kobayashi, Y., Kuhara, T., Oki, M. & Xiao, J. Z. Effects of Bifidobacterium breve A1 on the cognitive function of older adults with memory complaints: a randomised, double-blind, placebo-controlled trial. Benef. Microbes 10, 511\u2013520 (2019).","journal-title":"Benef. Microbes"},{"key":"511_CR84","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1038\/ajg.2010.281","volume":"105","author":"CW Png","year":"2010","unstructured":"Png, C. W. et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am. J. Gastroenterol. 105, 2420\u20132428 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"511_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0299-7","volume":"8","author":"J Chen","year":"2016","unstructured":"Chen, J. et al. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis. Genome Med. 8, 43 (2016).","journal-title":"Genome Med."},{"key":"511_CR86","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1194\/jlr.M039834","volume":"54","author":"JY Lee","year":"2013","unstructured":"Lee, J. Y. et al. Contribution of the 7beta-hydroxysteroid dehydrogenase from Ruminococcus gnavus N53 to ursodeoxycholic acid formation in the human colon. J. Lipid Res. 54, 3062\u20133069 (2013).","journal-title":"J. Lipid Res."},{"key":"511_CR87","doi-asserted-by":"publisher","first-page":"e0180673","DOI":"10.1371\/journal.pone.0180673","volume":"12","author":"WK Ko","year":"2017","unstructured":"Ko, W. K. et al. Anti-inflammatory effects of ursodeoxycholic acid by lipopolysaccharide-stimulated inflammatory responses in RAW 264.7 macrophages. PLoS ONE 12, e0180673 (2017).","journal-title":"PLoS ONE"},{"key":"511_CR88","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/S0006-2952(02)01391-6","volume":"64","author":"D Lapenna","year":"2002","unstructured":"Lapenna, D. et al. Antioxidant properties of ursodeoxycholic acid. Biochem. Pharmacol. 64, 1661\u20131667 (2002).","journal-title":"Biochem. Pharmacol."},{"key":"511_CR89","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1212\/WNL.0000000000001905","volume":"85","author":"H Mortiboys","year":"2015","unstructured":"Mortiboys, H. et al. UDCA exerts beneficial effect on mitochondrial dysfunction in LRRK2(G2019S) carriers and in vivo. Neurology 85, 846\u2013852 (2015).","journal-title":"Neurology"},{"key":"511_CR90","doi-asserted-by":"publisher","first-page":"135493","DOI":"10.1016\/j.neulet.2020.135493","volume":"741","author":"H Qi","year":"2021","unstructured":"Qi, H., Shen, D., Jiang, C., Wang, H. & Chang, M. Ursodeoxycholic acid protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis in MPTP\/MPP(+)-induced Parkinson\u2019s disease. Neurosci. Lett. 741, 135493 (2021).","journal-title":"Neurosci. Lett."},{"key":"511_CR91","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000518147","volume":"77","author":"M Hirayama","year":"2021","unstructured":"Hirayama, M. & Ohno, K. Parkinson\u2019s disease and gut microbiota. Ann. Nutr. Metab. 77, 28\u201335 (2021).","journal-title":"Ann. Nutr. Metab."},{"key":"511_CR92","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1136\/gutjnl-2020-323071","volume":"70","author":"A Agus","year":"2021","unstructured":"Agus, A., Clement, K. & Sokol, H. Gut microbiota-derived metabolites as central regulators in metabolic disorders. Gut 70, 1174\u20131182 (2021).","journal-title":"Gut"},{"key":"511_CR93","doi-asserted-by":"publisher","first-page":"105187","DOI":"10.1016\/j.micpath.2021.105187","volume":"160","author":"Z Yan","year":"2021","unstructured":"Yan, Z. et al. Alterations of gut microbiota and metabolome with Parkinson\u2019s disease. Microb. Pathog. 160, 105187 (2021).","journal-title":"Microb. Pathog."},{"key":"511_CR94","doi-asserted-by":"publisher","first-page":"e00561","DOI":"10.1128\/mSystems.00561-20","volume":"5","author":"S Vascellari","year":"2020","unstructured":"Vascellari, S. et al. Gut microbiota and metabolome alterations associated with Parkinson\u2019s disease. mSystems 5, e00561\u201320 (2020).","journal-title":"mSystems"},{"key":"511_CR95","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/biom11020144","volume":"11","author":"S Vascellari","year":"2021","unstructured":"Vascellari, S. et al. Clinical phenotypes of Parkinson\u2019s disease associate with distinct gut microbiota and metabolome enterotypes. Biomolecules 11, 144 (2021).","journal-title":"Biomolecules"},{"key":"511_CR96","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13024-021-00427-6","volume":"16","author":"VTE Aho","year":"2021","unstructured":"Aho, V. T. E. et al. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson\u2019s disease. Mol. Neurodegener. 16, 6 (2021).","journal-title":"Mol. Neurodegener."},{"key":"511_CR97","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ana.25982","volume":"89","author":"AH Tan","year":"2021","unstructured":"Tan, A. H. et al. Gut microbial ecosystem in Parkinson disease: new clinicobiological insights from multi-omics. Ann. Neurol. 89, 546\u2013559 (2021).","journal-title":"Ann. Neurol."},{"key":"511_CR98","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3233\/JPD-223179","volume":"12","author":"SJ Chen","year":"2022","unstructured":"Chen, S. J. et al. Alteration of gut microbial metabolites in the systemic circulation of patients with Parkinson\u2019s disease. J. Parkinsons Dis. 12, 1219\u20131230 (2022).","journal-title":"J. Parkinsons Dis."},{"key":"511_CR99","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ebiom.2018.03.030","volume":"30","author":"G Chen","year":"2018","unstructured":"Chen, G. et al. Sodium butyrate inhibits inflammation and maintains epithelium barrier integrity in a TNBS-induced inflammatory bowel disease mice model. EBioMedicine 30, 317\u2013325 (2018).","journal-title":"EBioMedicine"},{"key":"511_CR100","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1042\/bj2500819","volume":"250","author":"EP Brass","year":"1988","unstructured":"Brass, E. P. & Beyerinck, R. A. Effects of propionate and carnitine on the hepatic oxidation of short- and medium-chain-length fatty acids. Biochem. J. 250, 819\u2013825 (1988).","journal-title":"Biochem. J."},{"key":"511_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4611","volume":"5","author":"G Frost","year":"2014","unstructured":"Frost, G. et al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat. Commun. 5, 3611 (2014).","journal-title":"Nat. Commun."},{"key":"511_CR102","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1177\/0148607108322401","volume":"32","author":"D D\u2019Alessio","year":"2008","unstructured":"D\u2019Alessio, D. Intestinal hormones and regulation of satiety: the case for CCK, GLP-1, PYY, and Apo A-IV. J. Parenter. Enter. Nutr. 32, 567\u2013568 (2008).","journal-title":"J. Parenter. Enter. Nutr."},{"key":"511_CR103","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cell.2013.12.016","volume":"156","author":"F De Vadder","year":"2014","unstructured":"De Vadder, F. et al. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156, 84\u201396 (2014).","journal-title":"Cell"},{"key":"511_CR104","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","volume":"165","author":"A Koh","year":"2016","unstructured":"Koh, A., De Vadder, F., Kovatcheva-Datchary, P. & Backhed, F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165, 1332\u20131345 (2016).","journal-title":"Cell"},{"key":"511_CR105","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.cell.2016.10.043","volume":"167","author":"MS Desai","year":"2016","unstructured":"Desai, M. S. et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 167, 1339\u20131353 (2016). e1321.","journal-title":"Cell"},{"key":"511_CR106","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.chom.2015.09.002","volume":"18","author":"KA Earle","year":"2015","unstructured":"Earle, K. A. et al. Quantitative imaging of gut microbiota spatial organization. Cell Host Microbe 18, 478\u2013488 (2015).","journal-title":"Cell Host Microbe"},{"key":"511_CR107","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1528-y","volume":"16","author":"CH Lin","year":"2019","unstructured":"Lin, C. H. et al. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson\u2019s disease. J. Neuroinflammation 16, 129 (2019).","journal-title":"J. Neuroinflammation"},{"key":"511_CR108","doi-asserted-by":"publisher","first-page":"101966","DOI":"10.1016\/j.jchemneu.2021.101966","volume":"115","author":"MS Islam","year":"2021","unstructured":"Islam, M. S. et al. Pesticides and Parkinson\u2019s disease: current and future perspective. J. Chem. Neuroanat. 115, 101966 (2021).","journal-title":"J. Chem. Neuroanat."},{"key":"511_CR109","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.autrev.2019.03.016","volume":"18","author":"M Zoledziewska","year":"2019","unstructured":"Zoledziewska, M. The gut microbiota perspective for interventions in MS. Autoimmun. Rev. 18, 814\u2013824 (2019).","journal-title":"Autoimmun. Rev."},{"key":"511_CR110","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3390\/metabo11020120","volume":"11","author":"J Casani-Cubel","year":"2021","unstructured":"Casani-Cubel, J. et al. The impact of microbiota on the pathogenesis of amyotrophic lateral sclerosis and the possible benefits of polyphenols. An overview. Metabolites 11, 120 (2021).","journal-title":"Metabolites"},{"key":"511_CR111","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.micpath.2016.02.005","volume":"106","author":"M Derrien","year":"2017","unstructured":"Derrien, M., Belzer, C. & de Vos, W. M. Akkermansia muciniphila and its role in regulating host functions. Microb. Pathog. 106, 171\u2013181 (2017).","journal-title":"Microb. Pathog."},{"key":"511_CR112","doi-asserted-by":"publisher","first-page":"9066","DOI":"10.1073\/pnas.1219451110","volume":"110","author":"A Everard","year":"2013","unstructured":"Everard, A. et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl Acad. Sci. USA 110, 9066\u20139071 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"511_CR113","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1126\/science.1241165","volume":"341","author":"PM Smith","year":"2013","unstructured":"Smith, P. M. et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569\u2013573 (2013).","journal-title":"Science"},{"key":"511_CR114","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature12726","volume":"504","author":"N Arpaia","year":"2013","unstructured":"Arpaia, N. et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451\u2013455 (2013).","journal-title":"Nature"},{"key":"511_CR115","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.immuni.2013.12.007","volume":"40","author":"N Singh","year":"2014","unstructured":"Singh, N. et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40, 128\u2013139 (2014).","journal-title":"Immunity"},{"key":"511_CR116","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0304-3940(00)01294-5","volume":"289","author":"D Casper","year":"2000","unstructured":"Casper, D., Yaparpalvi, U., Rempel, N. & Werner, P. Ibuprofen protects dopaminergic neurons against glutamate toxicity in vitro. Neurosci. Lett. 289, 201\u2013204 (2000).","journal-title":"Neurosci. Lett."},{"key":"511_CR117","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1001\/archneur.60.8.1059","volume":"60","author":"H Chen","year":"2003","unstructured":"Chen, H. et al. Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch. Neurol. 60, 1059\u20131064 (2003).","journal-title":"Arch. Neurol."},{"key":"511_CR118","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/ana.20682","volume":"58","author":"H Chen","year":"2005","unstructured":"Chen, H. et al. Nonsteroidal antiinflammatory drug use and the risk for Parkinson\u2019s disease. Ann. Neurol. 58, 963\u2013967 (2005).","journal-title":"Ann. Neurol."},{"key":"511_CR119","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson, T. R. et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell 167, 1469\u20131480 (2016). e1412.","journal-title":"Cell"},{"key":"511_CR120","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neuro.2014.05.009","volume":"44","author":"R Bisht","year":"2014","unstructured":"Bisht, R., Kaur, B., Gupta, H. & Prakash, A. Ceftriaxone mediated rescue of nigral oxidative damage and motor deficits in MPTP model of Parkinson\u2019s disease in rats. Neurotoxicology 44, 71\u201379 (2014).","journal-title":"Neurotoxicology"},{"key":"511_CR121","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nn.4030","volume":"18","author":"D Erny","year":"2015","unstructured":"Erny, D. et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 18, 965\u2013977 (2015).","journal-title":"Nat. Neurosci."},{"key":"511_CR122","doi-asserted-by":"publisher","first-page":"1099018","DOI":"10.3389\/fnagi.2023.1099018","volume":"15","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson\u2019s disease by regulating gut microbiota. Front. Aging Neurosci. 15, 1099018 (2023).","journal-title":"Front. Aging Neurosci."},{"key":"511_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-27086-x","volume":"13","author":"ME Caetano-Silva","year":"2023","unstructured":"Caetano-Silva, M. E. et al. Inhibition of inflammatory microglia by dietary fiber and short-chain fatty acids. Sci. Rep. 13, 2819 (2023).","journal-title":"Sci. Rep."},{"key":"511_CR124","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36497-x","volume":"14","author":"DA Hall","year":"2023","unstructured":"Hall, D. A. et al. An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson\u2019s disease participants. Nat. Commun. 14, 926 (2023).","journal-title":"Nat. Commun."},{"key":"511_CR125","unstructured":"Braak, H. & Tredici, K. D. Neuroanatomy and pathology of sporadic Parkinson\u2019s disease. Adv. Anat. Embryol. Cell Biol. 201, 1\u2013119 (2009)."},{"key":"511_CR126","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-015-1485-1","volume":"131","author":"T Uchihara","year":"2016","unstructured":"Uchihara, T. & Giasson, B. I. Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol. 131, 49\u201373 (2016).","journal-title":"Acta Neuropathol."},{"key":"511_CR127","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02280-2","volume":"18","author":"S Milde","year":"2021","unstructured":"Milde, S. et al. Inflammatory neuronal loss in the substantia nigra induced by systemic lipopolysaccharide is prevented by knockout of the P2Y(6) receptor in mice. J. Neuroinflammation 18, 225 (2021).","journal-title":"J. Neuroinflammation"},{"key":"511_CR128","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1212\/WNL.0000000000004919","volume":"90","author":"IG McKeith","year":"2018","unstructured":"McKeith, I. G. Author response: diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 90, 300\u2013301 (2018).","journal-title":"Neurology"},{"key":"511_CR129","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.parkreldis.2009.12.010","volume":"16","author":"K Kashihara","year":"2010","unstructured":"Kashihara, K., Imamura, T. & Shinya, T. Cardiac 123I-MIBG uptake is reduced more markedly in patients with REM sleep behavior disorder than in those with early stage Parkinson\u2019s disease. Parkinsonism Relat. Disord. 16, 252\u2013255 (2010).","journal-title":"Parkinsonism Relat. Disord."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00511-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00511-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00511-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T03:04:25Z","timestamp":1683255865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00511-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,5]]},"references-count":129,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["511"],"URL":"https:\/\/doi.org\/10.1038\/s41531-023-00511-2","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,5]]},"assertion":[{"value":"20 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Human studies performed in our laboratory were approved by the Ethical Review Committees of the Nagoya University Graduate School of Medicine (approval #2016-0151), Iwate Medical University (H28-123), Okayama Kyokuto Hospital (approval #kyoIR-2016002), and Fukuoka University School of Medicine (approval #2016M027).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"71"}}